Based on previous research results, BTNs play important roles in cancer immunity, which might serve as new targets or therapeutic strategies and may be effective for anti–PD-1 or anti–cytotoxic T-lymphocyte-associated protein 4–unresponsive patients. Here, CTLA4 is linked to cancer.